The median estimate represents a +20. 22% in a total of its share price and finished its trading at 0. The Company operates through the identification and development of oncology therapeutics segment. Get the latest Onconova Therapeutics, Inc. Get a FREE analysis on ONTX now. Common Stock (ONTX) at Nasdaq. 23 September 2019 Onconova Therapeutics, Inc. 18, 1,739,600 shares traded hands during trading. Video: 5 Most Popular Stock Among Hedge Funds Hedge funds' top stock picks are performing spectacularly so far in the fourth quarter. See ONTX stock predictions by 1 financial experts and find out if their Onconova Therapeutics stock forecast (ONTX) is more bullish in comparison to other stocks in the Healthcare sector. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Dr. Market cap: C$110. 5 analysts have issued 1 year price targets for Outlook Therapeutics' shares. This is compared to its latest closing price of $0. ONTX investment & stock information. Find the latest Earnings Report Date for Onconova Therapeutics, Inc. Despite 11% weekly losses, a prediction made by PlanB last month is still holding true, with the outlook for March already. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. 00 and a low estimate of 1. 30 to a day high of $0. Announces $3. 00, with a high estimate of 2. If you had invested $1,000 when the news came out, your investment would have been worth $1,229 after 1 month and $2,094 after 6 months. Find out if ONTX is the best investment for you. Onconova Therapeutics Inc. However, experts often say that, regardless of technique, accurately forecasting stock market performance is more a matter of luck. The Company operates through the identification and development of oncology therapeutics segment. 36% in the last day (Tuesday, 5th May 2020) from $0. Onconova Therapeutics, Inc. ONTX stock: Onconova Therapeutics Inc Current Rating. , Stock Symbol: SGMD, Industry: Cannabis, Total Posts: 34102, Last Post: 5/7/2020 1:22:10 AM. The average price target is $1. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. 27% from two days following the earnings release until the close just before its next earnings release - outperforming the overall stock market by 293%. Americanbulls. The company currently trades around $19 a share, representing a market cap of over $3. , valued at. Each share of common stock (or common stock equivalent) was sold in the offering together with a common warrant to purchase one share of common stock at an exercise price of $0. Onconova Therapeutics (ONTX) Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Article Related Press Releases ( 1 ) Stock Quotes (1) Comments (0) FREE Breaking. Drug pipeline database encompassing. 's ONTX lead candidate, rigosertib, which is a proprietary phase III small molecule, when it reports fourth-quarter 2019 results. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market GlobeNewswire +16. 49% : 5,009,535 : 50-Day. Enter any symbol for a free, instant analysis. Subscribe Now & Begin Receiving Stock News, Articles, Trade Alerts & MORE, all 100% FREE! We are your #1 source for all things Stocks, Subscribe Below! Get stock alerts, news & stock related alerts straight to your inbox!. 02/18/2020 08:00:10 AM. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced the nomination of biotech industry veteran Terri Shoemaker to the Company’s Board of Directors. It focuses on discovering and developing small molecule drug candidates to treat cancer. Buy, Sell or Hold? We'll analyze any stock symbol for free using our market-proven, technical analysis tools. It's the director's first buy since 2011. 36% in the last day (Tuesday, 5th May 2020) from $0. ST Invest is a wholly owned subsidiary of StockTwits, Inc. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Watch more ONTX Technical Analysis Videos: https. Onconova Therapeutics, Inc. 49 USD with a tiny market cap of 49 mil USD & having lost almost 90% of its cap in 2019 is another full of promises went bad biotech story. 10, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Find out if ONTX is the best investment for you. 09 percent on Tuesday, January 21, 2020, on 1. November 21, 2019 - Onconova entered into a Distribution, License and Supply Agreement with Knight Therapeutics Inc. ONTX shares had a relatively better volume day versus average trading capacity of 22. Stock Price Forecast The 3 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 2. The median estimate represents a +20. Penny Stocks (PennyStocks. See Onconova Therapeutics, Inc. Street forecast for the quarter ending Dec 2019 is $-0. your password. We now and then issue mid-day momentum, breakout and news catalyst alerts by text and email. Securities and Exchange Commission reporting information. In depth view into ONTX (Onconova Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. The average price target is $1. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Dr. 60 pretty fast and that worries me. NEWTOWN, Pa. Please read important legal disclosures. Onconova Therapeutics Inc (ONTX:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. 00 and a low estimate of 80. 20 million shares in the current float. Over the past year the S&P 500 has gained 19. 69 percent to see the stock exchange hands at $0. 5 factor) to activity at the beginning of the period. Salesforce. The Company operates through the identification and development of oncology therapeutics segment. 30 million, with 151. ONTX Stock Analysis Overview. View Onconova Therapeutics, Inc. Today's volume of 501,176 shares is on pace to be much greater than ONTX's 10-day average volume of 5,567,363 shares. ONTX Stock Predictions. View Analyst Price Targets for Outlook. Penny Stocks (PennyStocks. The one-year Onconova Therapeutics Inc. I Know First and FinBrain are two we look at here. 10 per share for the quarter. Zomedica Pharmaceuticals Corp. ONTX Stocks 13. ONTX investment & stock information. ONTX from the largest community of traders and investors. Keep up to date with your stocks, cryptocurrencies, ETFs, and mutual funds in single portfolio. 14% increase from the last price of 110. Forgot your password? Password recovery. Therefore, Americanbulls. 3061$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). : ONTX 56% v76M c. View the real-time ONTX price chart on Robinhood and decide if you want to buy or sell commission-free. com Nov 25, 2019 7:11 pm Onconova Therapeutics, Inc. Other Events. Penny stocks available to trade in the RobinHood mobile stock trading app. 10% while insider ownership was 0. Member FINRA / SIPC. 306 until finishing in the latest session at $0. 7 million shares of common stock at $0. 59% above the 52 week low of 0. Do not miss these reports, be sure you subscribe to both TEXT, EMAIL alerts (scroll down and enter your email and cell phone number in the fields below) and download our mobile APP by searching “Stock Tips” or “Traders News Source” on the app store or google play. 's stock price was made on the Sept. View Onconova Therapeutics, Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. It is focused on discovering and developing small molecule drug candidates to treat cancer. Securities and Exchange Commission reporting information. Find the latest Onconova Therapeutics, Inc. Day Trading Blog - This Stock Blog gives insight on daily stock market trading as well as stock trading analysis. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Video: 5 Most Popular Stock Among Hedge Funds Hedge funds' top stock picks are performing spectacularly so far in the fourth quarter. 10 and a one year high of $4. Traders may consider selling the stock or exploring put options. ONTX Onconova Therapeutics Inc. Too many Americans got rich too quick, so billionaires want this system banned. Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020. The average equity rating for ONTX stock is currently 2. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer. 1% since the beginning of 2019. Onconova Therapeutics, Inc. 40 and traded as low as $0. Some of the statements in this report are forward-looking statements within the meaning of Section27A of. Mergers and Acquisitions: Top 7 M&A Targets of 2018 These stocks are all potential buyout targets, but for different reasons. Follow along and learn as I perform a quick stock chart technical analysis review on the Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced the nomination of biotech industry veteran Terri Shoemaker to the Company’s Board of Directors. and other biotech binary events. TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. 02/18/2020 08:00:10 AM. ONTX Stock Analysis Overview. Commitments and contingencies Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' (deficit) equity: Preferred Stock, Value, Issued Preferred stock, $0. Salesforce. 10, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Nice (NASDAQ:NICE) last posted its quarterly earnings results on […]. Common Stock (ONTX) at Nasdaq. 00 and a low estimate of 80. 03 from the previous closing price of $0. 00 and a low forecast of $1. Onconova Therapeutics, Inc. 00 in the next twelve months. ONTX is lower by -$0. ONTX Poststream. As of late, it has definitely been a great time to be an investor of Onconova Therapeutics, Inc. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. 41 per share. Traders may consider selling the stock or exploring put options. The market cap for the stock reached $74. A definitive agreement has been reached for Charles Schwab to acquire TD Ameritrade. The ONTX stock forecast is provided by MarketClub with their Trade Triangle system. Onconova stock historical price chart. 3061$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Get the latest Onconova Therapeutics, Inc. 08%: Dec-23-19 07:33PM : Onconova Therapeutics, Inc. Their forecasts range from $4. , biopharmaceutical company's common stock began trading on a split-adjusted basis Wednesday under the symbol "ONTX" on the Nasdaq Capital Market. The company has […]. Dependable, professional service. ONTX Stock Analysis Overview. The average price target is $1. NEWTOWN, Pa. Common Stock (ONTX) Onconova Therapeutics (ONTX) based on 1 analysts' forecasts, the consensus EPS forecast for the. Common Shares (ZOM) Company Bio Zomedica Pharmaceuticals Corp. ONTX(Onconova Therapeutics) a biotech company, hard-beaten by the markets the previous years show some signs of life and may be close to a strong reversal. This suggests a possible upside of 842. This is a signal that ONTX 's price could be shifting from an uptrend to a downtrend. Stock Price Forecast The 3 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 2. What i mean by that is this stock is up over 115% in the past month and that is a lot! Today we held at a pretty good resistance level of around $6. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. Other Events. Top Penny Stocks. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that the Company will release its first quarter financial results on Thursday, May 14, 2020, after the market closes. Friday, Apr 24, 2020. 15 by the wider market, as ONTX's P/S ratio currently stands at 17. Find the latest Onconova Therapeutics, Inc. Now(closing of 1/3/2020) at a price of 0. The company. Total capital return value is set at -255. I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. We use big data and artificial intelligence to forecast the stock price of Inpixon - INPX. 27 which saw uptrend of -87. Wainwright had Reiterated the stock as a Buy on March 01, 2018. Dive deeper with interactive charts and top stories of ONCONOVA THERAPEUTICS, INC. There are many techniques to use to forecast the stock market. 7% in the past month, while it is also above its 20 Day SMA too. Analysts expect the company to announce earnings of ($0. ALT Stock Forecast and Technical Analysis Sell candidate since 2020-05-06 Gain 0. 30 price objective on shares of Onconova […]. 41M April 22, 2020: 51. 4-exit filing)* Under the Securities Exchange Act of 1934 Onconova Therapeutics, INC. Should I buy or sell ONTX stock? If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. The stock has moved higher by 20. Regulation FD Disclosure On December1, 2018, promising results were presented from a Phase 2 clinical trial. Onconova Therapeutics Inc (NASDAQ:ONTX) shares crossed below its two hundred day moving average during trading on Thursday. ONTX Stock Forecast. 2020 is expected to be a huge year for penny stocks. Find the latest Earnings Report Date for Onconova Therapeutics, Inc. Drug pipeline database encompassing. Onconova (NASDAQ: ONTX), of Newtown, is selling just under 27. Earnings estimates for At Home Group Inc's (NYSE:HOME, Recent Price: 1. earnings per share revisions and analysts forecast | Nasdaq: ONTX | Nasdaq. Onconova Therapeutics Inc. ONTX updated stock price target summary. " The new CUSIP number for the common stock following the reverse stock split is 68232V. The Earnings Whisper Grade identifies where a stock is in the Earnings Expectation Life Cycle with the A+'s being in the Positive Earnings stage and, on average, gaining 7. Penny Stock Screener. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation. 23 September 2019 Onconova Therapeutics, Inc. ONTX shares had a relatively better volume day versus average trading capacity of 22. 2939 f38M We were in the ball park until 11/20 big sell day! What a BEAR trap, s - #5607479. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart. 2020-05-07 08:00 ET - News Release. (ONTX) Is Burning These Hedge Funds "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. ONTX closed up 118. Recover your. 49 USD with a tiny market cap of 49 mil USD & having lost almost 90% of its cap in 2019 is another full of promises went bad biotech story. However, experts often say that, regardless of technique, accurately forecasting stock market performance is more a matter of luck. Top Penny Stocks. 14% increase from the last price of 110. Video: 5 Most Popular Stock Among Hedge Funds Hedge funds' top stock picks are performing spectacularly so far in the fourth quarter. (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that it has entered into definitive agreements with [two] healthcare-focused institutional. com) is the top online destination for all things Micro-Cap Stocks. Onconova Therapeutics Inc (ONTX) stock has fallen -8. Onconova Therapeutics Inc (ONTX:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market GlobeNewswire +16. I think were gonna see some euphoria based runs around bio/tech/oil this year and will be posting some big hitter charts moving forward. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. View the real-time ONTX price chart on Robinhood and decide if you want to buy or sell commission-free. (NASDAQ: ONTX) ("Onconova" or the "Company"), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that it has entered into definitive agreements with [two] healthcare-focused institutional. Drug pipeline database encompassing. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Onconova Therapeutics, Inc. Thousands of new, high-quality pictures added every day. Stocks with an. 27 which saw uptrend of -87. 30% run ups in the last month I've charted. ONTX investment & stock information. 98% over the past 2 weeks. 45% from a day low at $0. The all-time high CTI BioPharma stock closing price was 878344. Table of Contents. 8% from the stock's current price. In depth view into ONTX (Onconova Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. View today's stock price, news and analysis for Onconova Therapeutics Inc. 31, with the high estimate being $2. Onconova Therapeutic stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 05) per share for the quarter. November 21, 2019 - Onconova entered into a Distribution, License and Supply Agreement with Knight Therapeutics Inc. 27% in the last day ( Wednesday, 6th May 2020 ) from $3. For short interest stock data, please contact us via email: [email protected] ONTX Stock Predictions. Stock Price Forecast The 3 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 2. Broad pipeline includes novel drug candidates in phase 3, early stage clinical, and pre-clinical trials. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Announces $3. Should I buy or sell ONTX stock? If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. gov - 3 - SECURITIES AND EXCHANGE COMMISSION Washington, D. The company's performance over the previous four quarters has been mixed. You can buy and sell Onconova Therapeutics (ONTX) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. Green Shoots Begin Breaking Through Key Stock Downtrends – Above the 40. 20 per share. View the latest ONTX stock quote and chart on MSN Money. , (ONTX) shares ended December 12, 2019 trading at $0. Onconova Therapeutic is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. ONTX is lower by -$0. 19 2013, 11:40 AM ET. A definitive agreement has been reached for Charles Schwab to acquire TD Ameritrade. Online Stock Comparison - Compare Onconova Therapeutics, Inc. stock futures gave up overnight gains and pointed to losses for the Dow at Thursday’s open. The best long-term & short-term Onconova Therapeutics share price prognosis for 2020, 2021. Penny Stocks (PennyStocks. Forgot your password? Password recovery. It's that easy. Get up to $600 when you fund your account* Open new account. ONTX investment & stock information. The trend analysis tool will help you make a better prediction on the ONTX stock. Each share of common stock (or common stock equivalent) was sold in the offering together with a common warrant to purchase one share of common stock at an exercise price of $0. Fruchtman, President and Chief Executive Officer, will present a company update at the BIO CEO & Investor. iShares Diversified Alternatives Trust ETF fell by -1. Investors will focus on Onconova Therapeutics, Inc. Onconova Therapeutics, Inc Stock Price Forecast, "ONTX" Predictons for2020. Find the latest analyst research for Onconova Therapeutics, Inc. AI Stock Market Prediction Software, Tools and Apps. 7% in the past month, while it is also above its 20 Day SMA too. 41 per share. 32 During the day the stock fluctuated 9. com you will find a comprehensive list of Penny Stocks & discover the best Penny Stocks to buy, top penny stock news and micro-cap stock articles. (ONTX) to four other stocks with NASDAQ. is a clinical-stage biopharmaceutical company. Now(closing of 1/3/2020) at a price of 0. Americanbulls. Forgot your password? Password recovery. NEWTOWN, Pa. 12% lower in the opening minutes of trading following the earnings release to change hands at 48. / TYNDALL CAPITAL PARTNERS L P - AMENDMENT NO. Emerging Growth Factors and Regional Forecast to. 1% since the beginning of 2019. 20 per share. This is a signal that ONTX 's price could be shifting from an uptrend to a downtrend. Learn about ONTX with our data and independent analysis including price, star rating, valuation, dividends, and financials. 28 per unit. However, experts often say that, regardless of technique, accurately forecasting stock market performance is more a matter of luck. Traders may consider selling the stock or exploring put options. The company's performance over the previous four quarters has been mixed. Find out if ONTX is the best investment for you. Dive deeper with interactive charts and top stories of ONCONOVA THERAPEUTICS, INC. The ONTX stock forecast is provided by MarketClub with their Trade Triangle system. Onconova Therapeutic is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. What this means: InvestorsObserver gives Onconova Therapeutic (ONTX) an overall rank of 38, which is below average. Should I buy or sell ONTX? The ONTX stock will be analyzed using Smart Scan and the Trade Triangle technology. 33 on October 20, 2000. Onconova Therapeutics has a 1-year low of $0. For Sale Price: $55000 | 2 bed, 2 bath, 15682 Sq. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. Data for this Date Range ; April 23, 2020: 50. Video: 5 Most Popular Stock Among Hedge Funds Hedge funds' top stock picks are performing spectacularly so far in the fourth quarter. com member(s) [ on a scale of (Strong Buy) 1. 2020 is expected to be a huge year for penny stocks. CHK ONTX INFN (PACD awaiting take off) (OAS next). The trend analysis tool will help you make a better prediction on the ONTX stock. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market GlobeNewswire +16. ONTX has been the subject of a number of other research reports. com you will find a comprehensive list of Penny Stocks & discover the best Penny Stocks to buy, top penny stock news and micro-cap stock articles. Bucks County biopharm firm plans $10M stock sale American City Business Journals +8. Watch more ONTX Technical Analysis Videos: https. 10 and has now fallen 3 days in a row. 01 par value, 5,000,000 authorized at December 31, 2017 and 2016, none issued and outstanding at December 31, 2017 and 2016 Common Stock. 3 TO THE SCHEDULE 13D Activist Investment 02-19 sec. was unable to take a rebound, for. Total capital return value is set at -255. Onconova Therapeutics (NASDAQ:ONTX) will be posting its quarterly earnings results after the market closes on Tuesday, March 24th. dvisor looked back and found 21 similar cases where ONTX 's RSI Indicator left the overbought zone, and in of them led to a successful outcome. Find the latest Onconova Therapeutics, Inc. The average CTI BioPharma stock price for the last 52 weeks is 0. 4-exit filing)* Under the Securities Exchange Act of 1934 Onconova Therapeutics, INC. PDUFA and Advisory Committee. NEWTOWN, Pa. Do not miss these reports, be sure you subscribe to both TEXT, EMAIL alerts (scroll down and enter your email and cell phone number in the fields below) and download our mobile APP by searching “Stock Tips” or “Traders News Source” on the app store or google play. Barchart takes this Alpha and weights this, assigning more weight to recent activity, and less (0. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. The latest rating update was made on Dec. Reports are indicating that there were more than several insider trading activities at Onconova Therapeutics, Inc. 30 price objective on shares of Onconova […]. Onconova Therapeutic (ONTX) reports earnings on 3/24/2020. ONTX is up 3. See ONTX stock predictions by 1 financial experts and find out if their Onconova Therapeutics stock forecast (ONTX) is more bullish in comparison to other stocks in the Healthcare sector. View Onconova Therapeutics, Inc. 13 Tuesday's Volume: 118,000 Three-Month Average Volume: 266,502. Commission-free online trading † Objective, third-party research. As you know, historical movements and returns are not indicative of future gains or market movement. ONTX is rated 3. Year End 31st Dec 2014 2015 2016 2017 2018 2019 TTM 2020E 2021E CAGR / Avg. Onconova Therapeutics stock traded up $0. 30% run ups in the last month I've charted. 65 with a high forecast of $2. Onconova Therapeutics Inc (NASDAQ:ONTX) shares crossed below its two hundred day moving average during trading on Thursday. Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug STA secures exclusive commercialisation rights for AU and NZ. ONTX stock is still attracting buyers after the company announced an exclusive licensing deal back on December 18, 2019. Previous Rating. As a private members-only community, the ONTX message board discussions and further stock rating information, including commentary by the 1 member(s) entering the ratings, is available to. The best long-term & short-term Onconova Therapeutics. The stock’s estimated price-earnings (P/E) multiple is 0 which is also below the 12-month price-earnings (P/E) which stands at 0. 59% above the 52 week low of 0. Common Shares (ZOM) Company Bio Zomedica Pharmaceuticals Corp. 40 and traded as low as $0. com's stock comparison tool. The company's stock opened Thursday at $0. 26% from average 12-month price target of $6. ONTX Stock Predictions. 62 , which is 38% below the current share price. 03 from the previous closing price of $0. A decline of 14% from the average session volume of 2,022,347 shares. 01 par value PER SHARE (Title of Class of. Find the latest Earnings Report Date for Onconova Therapeutics, Inc. Find the latest analyst research for Onconova Therapeutics, Inc. Micro cap companies are the stocks where their stock price is low, usually under $1 per share. As of late, it has definitely been a great time to be an investor of Onconova Therapeutics, Inc. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. 11 for a total of $202,200. , (ONTX) shares ended December 12, 2019 trading at $0. Bucks County biopharm firm plans $10M stock sale American City Business Journals +8. 02 and last traded at $5. 0 of the 3 analysts rate the stock as a "Sell. Persons interested in participating in the company’s earnings conference call can do so using this link. Will Onconova Therapeutics Inc NASDAQ:ONTX meet your expectations? Onconova Therapeutics Inc headquartered in Pennsylvania, United States is reporting their earnings on 03/24/2020 after the bell. (ONTX) Is Burning These Hedge Funds "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. 1 per share. Several brokerages recently weighed in on […]. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Onconova Therapeutics stock traded up $0. Follow along and learn as I perform a quick stock chart technical analysis review on the Onconova Therapeutics, Inc. 95% increase from the last price of 0. From a technical perspective, ONTX ripped sharply higher here right above. , valued at. 0 analysts. It beat earnings estimates in three, while missed in one of the trailing four quarters, with the average positive surprise being 11. Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Onconova Therapeutics, Inc. ONTX, Onconova Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. 00 on average by 1 ValueForum. The shares of common stock described above were offered and sold by the Company pursuant to a "shelf" registration statement on Form S-3 (Registration No. 93 million shares, but with a 0. Common Stock (ONTX) Earnings Report Date nasdaq. We use big data and artificial intelligence to forecast the stock price of Inpixon - INPX. 20 million shares in the current float. Online Stock Comparison - Compare Onconova Therapeutics, Inc. (Name of Issuer) Common STOCK, $0. In the short term (2weeks), ONTX's stock price should underperform the market by -0. As of now, ONTX has a P/S, P/E and P/B values of 21. NEWTOWN, Pa. (ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes, today announced the closing of its previously announced registered direct offering of 27,662,518 shares of its common stock at a purchase price of $0. 333-221684. 35 percent on Friday, May 1, 2020, on 57 percent of normal volume. ONTX Stock Predictions. Broad pipeline includes novel drug candidates in phase 3, early stage clinical, and pre-clinical trials. Onconova Therapeutics, Inc. Dates of upcoming clinical catalysts. When an order is placed, the buyer or seller has an obligation to purchase or sell their shares. 00 respectively. The trend analysis tool will help you make a better prediction on the ONTX stock. Broad pipeline includes novel drug candidates in phase 3, early stage clinical, and pre-clinical trials. This suggests a possible upside of 842. Stock Price Forecast The 3 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 2. analyst estimates by MarketWatch. ONTX is up 3. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. 27 which saw uptrend of -87. ONTX closed up 118. How do these AI. View ONTX revenue estimates and earnings estimates, as well as analyst recommendations. Forecast Cash Runway: ONTX has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 22. The price has fallen in 5 of the last 10 days , but is still up by 0. your password. 00, with a high estimate of 2. The company's stock had a trading volume of 35,471,285 shares, compared to its average volume of 17,795,355. com) is the top online destination for all things Micro-Cap Stocks. PDUFA and Advisory Committee. 8% from the stock's current price. Get breaking news and analysis on Onconova Therapeutics, Inc. NEWTOWN, Pa. (NASDAQ:ONTX) Files An 8-K Regulation FD DisclosureItem 7. ONTX closed down 2. Onconova Therapeutics, Inc. / 683 Capital Management, LLC - AMENDMENT NO. It focuses on the discovery, development, and commercialization of drugs, novel drug delivery systems, devices, and diagnostics for the health and wellness of companion animals, such. ONTX Stocks 13. Weekly Watchlist. Forecast Cash Runway: ONTX has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 22. Onconova Therapeutics (ONTX) Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Article Related Press Releases ( 1 ) Stock Quotes (1) Comments (0) FREE Breaking. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. Single Family Residential. Drug pipeline database encompassing. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer. Real time Onconova Therapeutics (ONTX) stock price quote, stock graph, news & analysis. About the Onconova Therapeutics, Inc stock forecast As of 2020 May 09, Saturday current price of ONTX stock is 0. 30 price objective on shares of Onconova […]. A review of movers and shakers while. Investing in securities products involves risk, including possible loss of principal. Get up to $600 when you fund your account* Open new account. gov - 3 - SECURITIES AND EXCHANGE COMMISSION Washington, D. 20 per share. your password. I am an amateur investor. The net margin for Onconova Therapeutics, Inc. Q1, 2020, 2021 Earnings Estimates for Whitestone REIT Increased 6:10AM ET 4/26/2020 MT Newswires. The company’s performance over the previous four quarters has been mixed. 00 for the present operating margin and +99. Find out if ONTX is the best investment for you. It's that easy. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. The company's performance over the previous four quarters has been mixed. Zacks' proprietary data indicates that Onconova Therapeutics, Inc. ONTX Stock Fundamentals. View the real-time ONTX price chart on Robinhood and decide if you want to buy or sell commission-free. Data for this Date Range ; April 23, 2020: 50. your username. The average equity rating for ONTX stock is currently 2. 28 per unit. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced the nomination of biotech industry veteran Terri Shoemaker to the Company’s Board of Directors. Sugarmade to Exercise Option to Acquire BZRTH, LLC Further Expanding its Presence in Cannabis Supplies Sector (Feb 2019) MONROVIA, CA -- February 6, 2019-- InvestorsHub NewsWire -- Sugarmade, Inc. all SEC filings breakout by MarketWatch. ONTX, Onconova Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. (ONTX) shares reached a high of $0. 7 million shares of common stock at $0. 33 on October 20, 2000. Get a free ONTX technical analysis report to make a better ONTX stock predictions on how the stock will perform in the near future. Thousands of new, high-quality pictures added every day. The Company operates through the identification and development of oncology therapeutics segment. 22% in a total of its share price and finished its trading at 0. The best penny stocks today shows the biggest penny stock gainers whereas the biggest penny stock losers is showing on the right. ( ONTX ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion By continuing to use our service, you agree to our use of cookies. ONTX stock reached 52-week highs on May at $4. During that period the price should oscillate between -13. Micro cap companies are the stocks where their stock price is low, usually under $1 per share. The latest rating update was made on Dec. 30 versus $0. 41% in the last trading day (Thursday, 7th May 2020), rising from $0. (ONTX) Is Burning These Hedge Funds Insider Monkey: Dec-19-19 01:44PM. Free, powerful trading platforms. Common Stock (ONTX) Onconova Therapeutics (ONTX) based on 1 analysts' forecasts, the consensus EPS forecast for the. Announces Closing of $11. Should I buy or sell ONTX stock? If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. (ONTX) aggregated in real time from around the web on NASDAQ. It beat earnings estimates in three, while missed in one of the trailing four quarters, with the average positive surprise being 11. KNIGHT THERAPEUTICS INC. 15 by the wider market, as ONTX's P/S ratio currently stands at 17. 31, with the high estimate being $2. ONTX opened at $0. via whalewisdomalpha 04/17/2020; Occidental Rides Out a Rocky Road 04/13/2020. SHOP stock is trading at 28 times this year’s revenue, while Okta (NASDAQ: OKTA) has a price-revenue multiple of roughly 27, and Zoom Video Communications’ (NASDAQ: ZM) multiple is closer to 40. The company's stock had a trading volume of 35,471,285 shares, compared to its average volume of 17,795,355. About the Onconova Therapeutics, Inc stock forecast As of 2020 May 09, Saturday current price of ONTX stock is 0. 62 , which is 38% below the current share price. com Nov 25, 2019 7:11 pm Onconova Therapeutics, Inc. 0 analysts. Welcome! Log into your account. Their forecasts range from $4. Now(closing of 1/3/2020) at a price of 0. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. The one-year Onconova Therapeutics Inc. 10% while insider ownership was 0. On PennyStocks. The list of top 5 stock picks didn’t change from Q2 to Q3. Onconova Therapeutics Inc. Forecast Cash Runway: ONTX has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 22. On 03-03-2020 (Tuesday), ONTX's stock construct a change of 7. (ONTX) stock price and volume charts for most recent trading day, 5-day, 1-month and longer monthly and yearly timeframes. Onconova Therapeutics (NASDAQ:ONTX) will be issuing its quarterly earnings data after the market closes on Tuesday, March 24th. View the real-time ONTX price chart on Robinhood and decide if you want to buy or sell commission-free. In general, a lower number or multiple is usually considered better that a higher one. Total capital return value is set at -255. 14% increase from the last price of 110. We use big data and artificial intelligence to forecast the stock price of Inpixon - INPX. It is focused on discovering and developing small molecule drug candidates to treat cancer. (ONTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 00 in the next twelve months. Common Stock (ONTX) at Nasdaq. As a disclosure, nothing mentioned is a recommendation to buy or sell stock, nor is this a prediction upon the direction of the market. your password. I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. 10 and a 1-year high of $4. Revenue came in at $491. 9% each year. ONTX Stock Predictions. ONTX Stock Fundamentals. Common Stock (ONTX) at Nasdaq. 63% Far from 50 Day Moving Average After a stumble in the market that brought ONTX to its low price for the period of the last 52 weeks, Onconova Therapeutics, Inc. things are looking really good for shareholders now,as everything is coming together for this stock,after all it was beat up pretty badly last year,and my purchase a couple of months ago was. As a private members-only community, the ONTX message board discussions and further stock rating information, including commentary by the 1 member(s) entering the ratings, is available to. ONTX stock reached 52-week highs on May at $4. dvisor looked back and found 21 similar cases where ONTX 's RSI Indicator left the overbought zone, and in of them led to a successful outcome. Traders and investors may also choose to study the ATR or Average True Range when concentrating on technical inventory assessment. We also list stocks to buy, top stocks, stock picks, and the best stocks to invest in 2020. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. After determining whether you'd like the rod mounted on the trim or the wall, allow a few extra inches on both ends of the window to give the curtains a place to hang while open. Weekly Watchlist. ONTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Onconova Therapeutic is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. 100% Upvoted. 13 Tuesday's Volume: 118,000 Three-Month Average Volume: 266,502. Stock analysis for Onconova Therapeutics Inc (ONTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 1 million up 1. What i mean by that is this stock is up over 115% in the past month and that is a lot! Today we held at a pretty good resistance level of around $6. Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020. 7 million shares of common stock at $0. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS. The Senate late Wednesday unanimously approved a historic $2 trillion coronavirus economic relief package, but 1 million to 4 million Americans are expected to have filed for unemployment benefits last week. Onconova Therapeutics, Inc. looking forward to the week ahead. Barchart takes this Alpha and weights this, assigning more weight to recent activity, and less (0. Get the latest Onconova Therapeutics, Inc. ONTX Stock Predictions. 01M April 21, 2020: 51. Onconova Therapeutics, Inc Stock Price Forecast, "ONTX" Predictons for2020. 20549 SCHEDULE 13G (Amendment No. Fruchtman, President and Chief Executive Officer, will present a company update at the BIO CEO & Investor Conference February 10-11, 2020. SHOP stock is trading at 28 times this year's revenue, while Okta (NASDAQ: OKTA) has a price-revenue multiple of roughly 27, and Zoom Video Communications' (NASDAQ: ZM) multiple is closer to 40. Drug pipeline database encompassing. 10% while insider ownership was 0. As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. Stock Price Forecast The 22 analysts offering 12-month price forecasts for Twilio Inc have a median target of 132. Investment property in Ulysses, PA. 20 million shares in the current float. 4 Passive Investment 02-14 sec. For Sale Price: $55000 | 2 bed, 2 bath, 15682 Sq. What this means: InvestorsObserver gives Onconova Therapeutic (ONTX) an overall rank of 46, which is below average.